Frank Verwiel
Chairman at INTELLIA THERAPEUTICS, INC.
Net worth: 299 956 $ as of 30/04/2024
Network origin in Frank Verwiel first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 79 | |
Subsidiary | Pharmaceuticals: Major | 31 | |
Public Company | Biotechnology | 31 | |
27
| Extinct | Biotechnology | 27 |
Public Company | Pharmaceuticals: Major | 27 | |
Subsidiary | Biotechnology | 23 | |
19
| Public Company | Pharmaceuticals: Major | 19 |
Aptalis Holdings, Inc.
Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
8
| Non-Profit Organization | Miscellaneous Commercial Services | 8 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999.
7
| Subsidiary | Biotechnology | 7 |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Frank Verwiel via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
TA SASU
TA SASU Pharmaceuticals: MajorHealth Technology Aptalis Pharma SAS is engaged in manufacturing pharmaceutical preparations. Its products include zenpep, canasa, carafate, pylera, rectiv, viokace, ultresa lacteol, delursan, panzytrat and salofalk. The company was founded in 1982 and is headquartered in Courbevoie, France. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman Director/Board Member | |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing President Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Sales & Marketing Human Resources Officer | |
OraPharma, Inc.
OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Founder Chief Executive Officer General Counsel Chief Operating Officer | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
HOSPIRA, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal General Counsel | |
University of Illinois | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Stanford University | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
ABBVIE INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Compliance Officer | |
INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Chairman Chief Operating Officer | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
VERACYTE, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
John Carroll University | College/University | Director/Board Member Director/Board Member | |
IEcure, Inc.
IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Biotechnology | Chief Executive Officer Director/Board Member | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | General Counsel Investor Relations Contact | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Northwestern University School of Law | College/University | Graduate Degree Graduate Degree | |
University of Connecticut | College/University | Graduate Degree Graduate Degree | |
CHIMERIX, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
United States | 44 |
France | 3 |
Denmark | 3 |
United Kingdom | 2 |
Canada | 2 |
Sectoral
Health Technology | 34 |
Consumer Services | 14 |
Health Services | 3 |
Finance | 2 |
Operational
Director/Board Member | 780 |
Independent Dir/Board Member | 267 |
Corporate Officer/Principal | 258 |
Chairman | 164 |
Chief Executive Officer | 99 |
Most connected contacts
Insiders | |
---|---|
Carl Gordon | 59 |
Fred Cohen | 58 |
James Healy | 50 |
Jean-Francois Formela | 47 |
Jonathan Leff | 45 |
Erik Gregers Hansen | 40 |
Perry Karsen | 38 |
Nessan Bermingham | 36 |
Rochelle Lazarus | 31 |
Jason S. Fisherman | 30 |
Fred Hassan | 29 |
Richard E. Maroun | 27 |
Caroline Dorsa | 27 |
Claus Tycho Bræstrup | 27 |
Stephen Sherwin | 26 |
- Stock Market
- Insiders
- Frank Verwiel
- Company connections